[Retracted] Targeting AraC‐Resistant Acute Myeloid Leukemia by Dual Inhibition of CDK9 and Bcl‐2: A Systematic Review and Meta‐Analysis
L Li, C Han, X Yu, J Shen, Y Cao - Journal of Healthcare …, 2022 - Wiley Online Library
Purpose. This study aims to determine the influence of targeting araC‐resistant acute
myeloid leukemia by dual inhibition cyclin‐dependent protein kinase (CDK9) and B‐cell …
myeloid leukemia by dual inhibition cyclin‐dependent protein kinase (CDK9) and B‐cell …
Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis
Acute myeloid leukemia (AML) is characterized by arrested differentiation making
differentiation therapy a promising treatment strategy. Recent success of inhibitors of …
differentiation therapy a promising treatment strategy. Recent success of inhibitors of …
Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia
Low-dose cytarabine (LDAC) is a standard therapy for elderly acute myeloid leukemia (AML)
patients unfit for intensive chemotherapy. While high doses of cytarabine induce cytotoxicity …
patients unfit for intensive chemotherapy. While high doses of cytarabine induce cytotoxicity …
Decoding the mechanism of Shen Qi Sha Bai decoction in treating acute myeloid leukemia based on network pharmacology and molecular docking
G Jia, X Jiang, Z Li, X Ding, L Lei, S Xu… - Frontiers in Cell and …, 2021 - frontiersin.org
Traditional Chinese Medicine (TCM) has been shown to be efficacious in treating leukemia
for thousands of years. It has been shown that Shen Qi Sha Bai Decoction (SQSBD) has …
for thousands of years. It has been shown that Shen Qi Sha Bai Decoction (SQSBD) has …
Bone Marrow Stromal Cells Enhance Differentiation of Acute Myeloid Leukemia Induced by Pyrimidine Synthesis Inhibitors
Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies
characterized by differentiation arrest, high relapse rates, and poor survival. The bone …
characterized by differentiation arrest, high relapse rates, and poor survival. The bone …
miR‑let‑7c‑3p targeting on Egr‑1 contributes to the committed differentiation of leukemia cells into monocyte/macrophages
F Qi, X Wang, S Zhao, C Wang, R Sun… - Oncology …, 2022 - spandidos-publications.com
In preliminary experiments, it was found that the expression of early growth response‑1 (Egr‑
1) was upregulated during the committed differentiation of leukemia cells into monocytes …
1) was upregulated during the committed differentiation of leukemia cells into monocytes …
[PDF][PDF] Barbara Tomic1, 2, Tomislav Smoljo1, 2, Hrvoje Lalic1, 2, Vilma Dembitz1, 2, Josip Batinic3
D Batinic, A Bedalov, D Visnjic - Scientific Reports, 2022 - bib.irb.hr
Acute myeloid leukemia (AML) is characterized by arrested differentiation making
differentiation therapy a promising treatment strategy. Recent success of inhibitors of …
differentiation therapy a promising treatment strategy. Recent success of inhibitors of …
Mehanizam diferencijacije stanica akutne mijeloične leukemije potaknute citarabinom
T Smoljo - 2024 - repozitorij.unizg.hr
Sažetak Citarabin u malim koncentracijama potiče diferencijaciju stanica akutne mijeloične
leukemije (AML), ali mehanizam nije u potpunosti objašnjen. Naša prethodna istraživanja …
leukemije (AML), ali mehanizam nije u potpunosti objašnjen. Naša prethodna istraživanja …